Evaluation of the Safety of Use of Anti-IL6 Receptor Antibodies to Reduce Allo-sensitization Post Allograft Nephrectomy
Clinical trial NCT04779957 · COMPLETED
Trial details
- NCT number
- NCT04779957
- Sponsor
- University Hospital, Toulouse
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-01
- Primary completion
- 2024-08-09
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.